UNSPSC 51333101: Azaquinzole

This classification denotes an antipsychotic agent with the molecular formula C12H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T3H6486135, chemically known as 1,3,4,6,7,11b-hexahydro-2h-pyrazino(2,1-a)isoquinoline but generally known as azaquinzole, which bears US NIH Compound Identifier 179345. European Medicines Agency schedules Azaquinzole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05639MIG. The term AZAQUINZOLE is an International Non-Proprietary Name.

Most nations schedule azaquinzole under HS 29335995 and SITC 51576. As of Q4 2014, AZAQUINZOLE remains the US FDA Preferred Term for this commodity. Azaquinzole bears US NLM identifiers UMLS ID C2346894 and NCI Concept Code C74173. SMILES:.

UNSPSC 51333101 Azaquinzole is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023—solicits naloxone and safe drug deactivation systems for community health initiatives, not azaquinzole, a fungicide active ingredient. The mismatch between the code's nominal scope and the actual procurement suggests either a tagging error in the source data or a fundamental misalignment between the UNSPSC classification and the goods being procured.

The Seminole County opportunity is the only recent state and local solicitation visible under this code. Without additional opportunities in the dataset, geographic spread and issuing-body concentration cannot be characterized. The code shows minimal relevant recent activity for business development purposes.